Aquestive rugi bersih GAAP Q2 FY26 melebar jadi USD 22,9 juta; revenue naik 38% jadi USD 13,8 juta

Reuters2026/08/11 20:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aquestive Therapeutics membukukan revenue kuartal II 2026 naik 38% menjadi $13,8 juta.
Rugi bersih GAAP melebar menjadi $22,9 juta; rugi per saham GAAP memburuk menjadi $0,18.
Adjusted EBITDA loss non-GAAP menyempit menjadi $5,2 juta dari $9,3 juta pada kuartal II 2025.
Kas dan setara kas per 30 Juni 2026 turun menjadi $98,5 juta.
Untuk Anaphylm, studi human factors dan PK selesai; tetap menargetkan resubmisi NDA pada kuartal III 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608111601PRIMZONEFULLFEED9808057) on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aquestive rugi bersih GAAP Q2 FY26 melebar jadi USD 22,9 juta; revenue naik 38% jadi USD 13,8 juta

You may also like

Crypto prices